🔎 Trials Near Me

Hem › Burkitts lymfom › Pennsylvania › Philadelphia

Kliniska studier för Burkitts lymfom i Philadelphia, PA

16 studier för Burkitts lymfom söker deltagare vid platser i och runt Philadelphia (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

RekryterarFas 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Ålder 1 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

RekryterarFas 1
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 0 till 18 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
366 Days – 46 Years · Alla kön · Uppdaterad 2 okt. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

RekryterarFas 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Ålder 18 till 39 · Alla kön · Uppdaterad 2 okt. 2026 · NCT03150693

Blinatumomab Consolidation in Real World

RekryterarObservationsstudieFriska volontärer välkomna
  • University of Pennsylvania, Philadelphia
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RekryterarObservationsstudie
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 0 till 38 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekryterarFas 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
Ålder 1 till 30 · Alla kön · Uppdaterad 1 sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi bort
365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekryterarFas 2
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 7 till 25 · Alla kön · Uppdaterad 19 aug. 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Rekryterar
  • Children's Hospital of Philadelphia, Philadelphia
Upp till ålder 25 · Alla kön · Uppdaterad 8 juli 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

RekryterarFas 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 0 till 29 · Alla kön · Uppdaterad 26 maj 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

RekryterarFas 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Upp till ålder 29 · Alla kön · Uppdaterad 27 mars 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

RekryterarFas 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Ålder 15 till 50 · Alla kön · Uppdaterad 9 sep. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

RekryterarFas 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi bort
Ålder 1 till 25 · Alla kön · Uppdaterad 4 maj 2025 · NCT03509961

Burkitts lymfom-studier i andra städer

Andra studier i Philadelphia

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.